Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Current Quarter	$-0.07	Next Quarter	$0.17
Current Year	$1.14	Next Year	$1.35
QoQ Growth	+342.9%	YoY Growth	+18.4%
3Y EPS CAGR	+47.1%	Target Price	$38.00
Consensus	Buy	Upside	+58.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TCMD	$23.96	-0.75%	254.20K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TCMD	$23.96	-0.7%	254.20K
3
4
5
6

TCMD

TCMD

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Tactile Systems Technology Inc. Data in Excel

Get Tactile Systems Technology Inc. Data in Excel